| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 03/11/1997 | US5610049 Human rotavirus HCR3A and method of growing said rotavirus |
| 03/11/1997 | US5610011 Virulence-encoding DNA sequences of Strepococcus suis and related products and methods |
| 03/11/1997 | US5610009 Mammalian expression systems for hepatitis C virus envelope genes |
| 03/11/1997 | CA2109435C Compositions of n-(phosphonoacetyl)-l-aspartic acid and methods of their use as broad spectrum antivirals |
| 03/06/1997 | WO1997008334A1 Cryptophycins from aberrant biosynthesis |
| 03/06/1997 | WO1997008310A1 Novel 3' terminal sequence of hepatitis c virus genome and diagnostic and therapeutic uses thereof |
| 03/06/1997 | WO1997008199A2 Antimicrobial cationic peptides and methods of screening for the same |
| 03/06/1997 | WO1997008191A1 Polymorphs of the prodrug 6-n-(l-ala-l-ala)-trovafloxacin |
| 03/06/1997 | WO1997008180A1 Method to improve the biological and antiviral activity of protease inhibitors |
| 03/06/1997 | WO1997008174A1 Interleukin converting enzyme and apoptosis |
| 03/06/1997 | WO1997008144A1 Substituted benzylaminopiperidine compounds |
| 03/06/1997 | WO1997008143A1 Inhibitors of tumor necrosis factor alpha |
| 03/06/1997 | WO1997007817A1 Multi-subtype fiv vaccines |
| 03/06/1997 | WO1997007802A1 Methods and compositions for treating fungal infections in mammals |
| 03/06/1997 | WO1997007800A1 Zwitterionic forms of trovafloxacin |
| 03/06/1997 | WO1997007798A1 Pharmaceutical compounds |
| 03/06/1997 | WO1997007791A1 Use of aminoadamantane compounds as immunoregulators |
| 03/06/1997 | WO1997002344A3 Vaccine for infectious agents, composition for treating and preventing hiv infections |
| 03/06/1997 | WO1996040929A3 Transferrin receptor genes |
| 03/06/1997 | WO1996040768A3 Anti-fungal and anti-bacterial histatin-based peptides |
| 03/06/1997 | WO1996023479A3 Anti-adhesive active principles |
| 03/06/1997 | CA2246117A1 Cryptophycins from aberrant biosynthesis |
| 03/06/1997 | CA2230856A1 Methods and compositions for treating fungal infections in mammals |
| 03/06/1997 | CA2230540A1 Pharmaceutical compounds |
| 03/06/1997 | CA2230487A1 Inhibitors of tumor necrosis factor alpha |
| 03/06/1997 | CA2230160A1 Antimicrobial cationic peptides and methods of screening for the same |
| 03/05/1997 | EP0760482A2 Method for judging eradication of H. pylori based on rates of changes in the pepsinogen I/II ratio |
| 03/05/1997 | EP0760394A1 Mild Newcastle disease virus vaccine |
| 03/05/1997 | EP0760014A1 Identification and use of antiviral compounds |
| 03/05/1997 | EP0760000A1 Alphavirus expression vector |
| 03/05/1997 | EP0759995A1 Fusion glycoprotein from hcmv and hsv |
| 03/05/1997 | EP0759992A1 Human papilloma virus inhibition by a hairpin ribozyme |
| 03/05/1997 | EP0759980A1 Interleukin-6 splice variant |
| 03/05/1997 | EP0759937A1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis c virus |
| 03/05/1997 | EP0759935A1 Recombinant papilloma virus l1 |
| 03/05/1997 | EP0759917A1 Novel selective inhibitors of viral or bacterial neuraminidases |
| 03/05/1997 | EP0759899A1 Nitro compounds and their compositions having anti-inflammatory, analgesic and anti-thrombotic acitivities |
| 03/05/1997 | EP0759780A1 Improved modified live brsv vaccine |
| 03/05/1997 | EP0759777A1 VACCINE FOR $i(MORAXELLA CATARRHALIS) |
| 03/05/1997 | EP0759775A1 IFN-$g(b) LIQUID FORMULATIONS |
| 03/05/1997 | EP0759774A1 Method of treating gram-negative bacterial infection by administration of bactericidal/permeability-increasing (bpi) protein product and antibiotic |
| 03/05/1997 | EP0759764A1 Composition for dental use comprising krill enzyme |
| 03/05/1997 | EP0759761A1 The use of dimeticone for the local antibacterial therapy and/or the prevention and therapy of helicobacter pylori (hp) associated syndromes and infectious diseases |
| 03/05/1997 | EP0759755A1 Thiadiazolylalkoxyphenyl derivatives, their preparation and their use anti-picornaviral agents |
| 03/05/1997 | EP0656064B1 Bispecific immunoadhesins |
| 03/05/1997 | EP0643069B1 2'-deoxy-2'-fluorocoformycin and stereoisomers thereof |
| 03/05/1997 | EP0620809B1 $g(a)-SUBSTITUTED BENZENEMETHANAMINE DERIVATIVES |
| 03/05/1997 | EP0548186B1 Cephalosporin derivatives and their homologues |
| 03/05/1997 | CN1144536A Novel mutated viruses, anti-viral compounds and novel methods of making vaccines |
| 03/05/1997 | CN1144489A Combinations of thrombolytically active proteins and anticoagulants, and uses thereof |
| 03/05/1997 | CN1144488A Novel remedy for respiratory-tract viral disease |
| 03/05/1997 | CN1144485A Adhesion inhibiting composition |
| 03/05/1997 | CN1144484A Acidified nitrite as an antimicrobial agent |
| 03/05/1997 | CN1144480A Guanylhydrazones for treating inflammatory conditions |
| 03/05/1997 | CN1144222A New cephem compounds |
| 03/05/1997 | CN1144121A Chinese medicine composite for preventing dental caries |
| 03/05/1997 | CN1144089A Water-soluble gossypol preparation and its preparing method |
| 03/04/1997 | US5608082 Compounds useful as antiproliferative agents and GARFT inhibitors |
| 03/04/1997 | US5608064 Purinyl salts useful for preparing guanine containing antiviral agents |
| 03/04/1997 | US5608056 Substituted 3-pyrrolidinylthio-carbapenems as antimicrobial agents |
| 03/04/1997 | US5608052 Enzyme inhibitors of beta-lactamase |
| 03/04/1997 | US5608049 Preparation of d4T from 5-methyluridine |
| 03/04/1997 | US5608048 Polymorphic forms of 2',3'-didehydro-3'-deoxythymidine useful in the treatment of aids |
| 03/04/1997 | US5608044 Pradimic acids, amides, and pradimicin derivatives |
| 03/04/1997 | US5608043 Process for the preparation of 2-deoxy-2,2-difluoro-β-D-ribo-pentopyranose compounds |
| 03/04/1997 | US5607974 Treatment of diseases associated with cysteine deficiency |
| 03/04/1997 | US5607942 Bactericides |
| 03/04/1997 | US5607932 Bactericides |
| 03/04/1997 | US5607929 Antiviral dibenzothiazepinone derivatives |
| 03/04/1997 | US5607928 Carbapenem derivatives containing a bicyclic ketone substituent and their use as anti-infectives |
| 03/04/1997 | US5607927 Cephalosporin derivative |
| 03/04/1997 | US5607922 1,5-anhydrohexitol nucleoside analogues |
| 03/04/1997 | US5607852 Process for attenuated varicella zoster virus vaccine production |
| 03/04/1997 | US5607851 Process for purifying hepatitis a virus (HAV), and vaccine compositions containing hepatitis a virus |
| 03/04/1997 | US5607847 Cells, monoclonal antibodies and hybridomas |
| 03/04/1997 | US5607846 Vaccine for moraxella catarrhalis |
| 03/04/1997 | US5607685 Protracted-release adminstration forms containing clindamycin palmitate |
| 03/01/1997 | CA2184146A1 Heterocyclically substituted pseudopeptides |
| 02/27/1997 | WO1997007214A1 Functional role of adrenomedullin (am) and the gene-related product (pamp) in human pathology and physiology |
| 02/27/1997 | WO1997007198A2 Dna sequences and secreted proteins encoded thereby |
| 02/27/1997 | WO1997007125A1 5'-substituted-ribofuranosyl benzimidazoles as antiviral agents |
| 02/27/1997 | WO1997007121A1 Purification process |
| 02/27/1997 | WO1997006818A1 Pharmaceutical compositions for competitively inhibiting the binding of a retrovirus to the ifn-receptor and means for diagnosis of an hiv infection |
| 02/27/1997 | WO1997006814A1 Method of promoting angiogenesis |
| 02/27/1997 | WO1997006811A1 Protection against pathogenic microorganisms |
| 02/27/1997 | WO1997006806A1 Use of prostane derivatives and the combination thereof with antibiotics in the treatment of bacterial infections |
| 02/27/1997 | WO1997006804A1 1,3-oxathiolane nucleoside analogues in the treatment of hepatitis c |
| 02/27/1997 | WO1997006802A1 Use of oxido-squalene cyclase inhibitors to lower blood cholesterol |
| 02/27/1997 | WO1997006798A2 Pharmaceutical formulations |
| 02/27/1997 | WO1997006790A1 Carotenoid-nicotinamide-zinc compositions and methods of treatment using same |
| 02/27/1997 | WO1997004005A3 Cyclosporin derivatives with anti-hiv effect |
| 02/27/1997 | WO1997003188A3 Use of mp52 or mp121 for treating and preventing diseases of the nervous system |
| 02/27/1997 | WO1997003082A3 Pyrimidine nucleoside derivatives |
| 02/27/1997 | DE19531342A1 Verwendung von Aminoadamantan-Verbindungen als Immunregulatoren Use of aminoadamantane compounds as immune regulators |
| 02/27/1997 | CA2229208A1 Dna sequences and secreted proteins encoded thereby |
| 02/27/1997 | CA2229135A1 Carotenoid-nicotinamide-zinc compositions and methods of treatment using same |
| 02/27/1997 | CA2228765A1 Pharmaceutical compositions for competitively inhibiting the binding of a retrovirus to the ifn-receptor and means for diagnosis of an hiv infection |
| 02/27/1997 | CA2228521A1 Protection against pathogenic microorganisms |
| 02/27/1997 | CA2228036A1 Use of prostane derivatives and the combination thereof with antibiotics in the treatment of bacterial infections |
| 02/27/1997 | CA2226735A1 Use of oxido-squalene cyclase inhibitors to lower blood cholesterol |